Publishing research using ab51772? Please let us know so that we can cite the reference in this datasheet.

ab51772 has been referenced in 7 publications.

  • Shi B  et al. MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells. Cell Mol Biol Lett 24:1 (2019). PubMed: 30873211
  • Zhang H  et al. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer. Int J Oncol 53:1118-1128 (2018). PubMed: 30015842
  • Huang M  et al. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell. BMC Gastroenterol 18:169 (2018). PubMed: 30400838
  • Kudinov AE  et al. Musashi-2 (MSI2) supports TGF-ß signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A 113:6955-60 (2016). WB . PubMed: 27274057
  • Sun Y  et al. Slug overexpression induces stemness and promotes hepatocellular carcinoma cell invasion and metastasis. Oncol Lett 7:1936-1940 (2014). WB, Flow Cyt ; Human . PubMed: 24932263
  • Hanai JI  et al. ATP citrate lyase knockdown impacts cancer stem cells in vitro. Cell Death Dis 4:e696 (2013). PubMed: 23807225
  • Kreiseder B  et al. a-Catulin downregulates E-cadherin and promotes melanoma progression and invasion. Int J Cancer : (2012). PubMed: 22733455

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up